Target animal safety studies of mavacoxib in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue SUPPL. 1, 2009, Pages 104-105

  Krautmann, M J ^a   Boucher, J F ^a   Cox, S R ^a   Savides, M C ^b   Stegemann, M R ^c  

^a ZOETIS   (United States)

^b Ricerca Inc   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; CYCLOOXYGENASE 2 INHIBITOR; LIVER ENZYME; MAVACOXIB; PLACEBO; UNCLASSIFIED DRUG;

ABNORMAL FECES; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; AREA UNDER THE CURVE; AUTOPSY; BASOPHILIA; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EXPERIMENTAL DOG; FEMALE; FOLLOW UP; FOOD INTAKE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL IRRITATION; INFLAMMATION; INTESTINE PERFORATION; KIDNEY TUBULE EPITHELIUM; MALE; MAXIMUM PLASMA CONCENTRATION; MUCOSAL BLEEDING; NONHUMAN; ORGAN WEIGHT; OSTEOARTHRITIS; PAIN; PERITONITIS; PRIORITY JOURNAL; TREATMENT DURATION; VOMITING;

ANIMALIA; CANIS FAMILIARIS;

EID: 68149091172     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)